Kim Lauper
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update.
Smolen J, Landewé R, Bergstra S, Kerschbaumer A, Sepriano A, Aletaha D, Caporali R, Edwards C, Hyrich K, Pope J, de Souza S, Stamm T, Takeuchi T, Verschueren P, Winthrop K, Balsa A, Bathon J, Buch M, Burmester G, Buttgereit F, Cardiel M, Chatzidionysiou K, Codreanu C, Cutolo M, den Broeder A, El Aoufy K, Finckh A, Fonseca J, Gottenberg J, Haavardsholm E, Iagnocco A, Lauper K, Li Z, McInnes I, Mysler E, Nash P, Poór G, Ristic G, Rivellese F, Rubbert-Roth A, Schulze-Koops H, Stoilov N, Strangfeld A, van der Helm-van Mil A, van Duuren E, Vliet Vlieland T, Westhovens R, van der Heijde D. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update. Ann Rheum Dis 2022
Nov 10, 2022EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update.
Nov 10, 2022Ann Rheum Dis 2022
Smolen Josef S, Landewé Robert B M, Bergstra Sytske Anne, Kerschbaumer Andreas, Sepriano Alexandre, Aletaha Daniel, Caporali Roberto, Edwards Christopher John, Hyrich Kimme L, Pope Janet E, de Souza Savia, Stamm Tanja, Takeuchi Tsutomu, Verschueren Patrick, Winthrop Kevin, Balsa Alejandro, Bathon Joan M, Buch Maya H, Burmester Gerd R, Buttgereit Frank, Cardiel Mario Humberto, Chatzidionysiou Katerina, Codreanu Catalin, Cutolo Maurizio, den Broeder Alfons A, El Aoufy Khadija, Finckh Axel, Fonseca João Eurico, Gottenberg Jacques-Eric, Haavardsholm Espen A, Iagnocco Annamaria, Lauper Kim, Li Zhanguo, McInnes Iain B, Mysler Eduardo F, Nash Peter, Poór Gyula, Ristic Gorica G, Rivellese Felice, Rubbert-Roth Andrea, Schulze-Koops Hendrik, Stoilov Nikolay, Strangfeld Anja, van der Helm-van Mil Annette, van Duuren Elsa, Vliet Vlieland Theodora P M, Westhovens René, van der Heijde Désirée
Type of mRNA COVID-19 vaccine and immunomodulatory treatment influence humoral immunogenicity in patients with inflammatory rheumatic diseases.
Raptis C, Berger C, Ciurea A, Andrey D, Polysopoulos C, Lescuyer P, Maletic T, Riek M, Scherer A, von Loga I, Safford J, Lauper K, Möller B, Vuilleumier N, Finckh A, Rubbert-Roth A. Type of mRNA COVID-19 vaccine and immunomodulatory treatment influence humoral immunogenicity in patients with inflammatory rheumatic diseases. Front Immunol 2022; 13:1016927.
Oct 13, 2022Type of mRNA COVID-19 vaccine and immunomodulatory treatment influence humoral immunogenicity in patients with inflammatory rheumatic diseases.
Oct 13, 2022Front Immunol 2022; 13:1016927
Raptis Catherine E, Berger Christoph T, Ciurea Adrian, Andrey Diego O, Polysopoulos Christos, Lescuyer Pierre, Maletic Tanja, Riek Myriam, Scherer Almut, von Loga Isabell, Safford Judith, Lauper Kim, Möller Burkhard, Vuilleumier Nicolas, Finckh Axel, Rubbert-Roth Andrea
Cohort profile: SCREEN-RA: design, methods and perspectives of a Swiss cohort study of first-degree relatives of patients with rheumatoid arthritis
Gilbert B, Moeller B, Kyburz D, Rubbert-Roth A, Courvoisier D, Studer O, Trunk E, Lauper K, Mongin D, Lamacchia C, Finckh A. Cohort profile: SCREEN-RA: design, methods and perspectives of a Swiss cohort study of first-degree relatives of patients with rheumatoid arthritis. BMJ Open 2021; 11:e048409.
Jul 14, 2021Cohort profile: SCREEN-RA: design, methods and perspectives of a Swiss cohort study of first-degree relatives of patients with rheumatoid arthritis
Jul 14, 2021BMJ Open 2021; 11:e048409
Gilbert Benoit Thomas P, Moeller Burkhard, Kyburz Diego, Rubbert-Roth Andrea, Courvoisier Delphine S, Studer Olivia, Trunk Eric, Lauper Kim, Mongin Denis, Lamacchia Céline, Finckh Axel
The prevalence of anticitrullinated protein antibodies increases with age in healthy individuals at risk for rheumatoid arthritis
Alpizar-Rodriguez D, Bas S, Gascon D, Lamacchia C, Roux-Lombard P, Lauper K, Nissen M, Courvoisier D, Gabay C, Mahler M, Zufferey P, Brulhart L, Müller R, Möller B, Dudler J, Ciurea A, Walker U, Von Mühlenen I, Kyburz D, Finckh A. The prevalence of anticitrullinated protein antibodies increases with age in healthy individuals at risk for rheumatoid arthritis. Clin Rheumatol 2017
Jan 21, 2017The prevalence of anticitrullinated protein antibodies increases with age in healthy individuals at risk for rheumatoid arthritis
Jan 21, 2017Clin Rheumatol 2017
Alpizar-Rodriguez D, Bas Sylvette, Gascon Danielle, Lamacchia Céline, Roux-Lombard Pascale, Lauper Kim, Nissen Michael J, Courvoisier Delphine S, Gabay Cem, Mahler Michael, Zufferey Pascal, Brulhart Laure, Müller Rüdiger, Möller Burkhard, Dudler Jean, Ciurea Adrian, Walker Ulrich A, Von Mühlenen Ines, Kyburz Diego, Finckh Axel